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1. Introduction 
Japanese encephalitis (JE) is widely distributed in most areas of Asia, particularly in eastern, 
southern, and southeastern Asia (Rosen 1986). It expanded to the Torres Strait of northern 
Australia in 1999, and has now become widespread in Australia (Mackenzie, 1999; 
Mackenzie et al., 2004). Mass vaccinations were implemented in a number of Asian 
countries such as Japan, Korea, China, Taiwan, Thailand, and India, leading to declines in 
the incidences of JE (Wu et al., 1999; Monath, 2002; Erlanger et al., 2009). Generally, swine 
serve as an amplifying host in the transmission cycle of the JE virus (JEV) (fig. 1), giving it 
an important role in the maintenance of the JEV in nature (Nidaira et al., 2009). Due to 
changes in the socioeconomic status, households that breed swine have sharply decreased in 
Japan and many other countries (Yoshida et al., 2005). Despite, an estimated 3 billion 
persons living in countries with endemic JE, it causes about 30,000~50,000 cases per year 
(Solomom, 2004; van den Hurk et al., 2008); among these, there are estimated to be 
10,000~15,000 human deaths yearly worldwide (Erlanger et al., 2009). The potential for the 
emergence of frontiers of JEV is now a new concern (Nett et al., 2009; van den Hurk et al., 
2009). 
The etiological agent of JE is one of about 70 members of the genus Flavivirus that belongs to 
the family Flaviviridae (Monath & Heinz, 1996). JEV frequently causes encephalitic diseases 
through bites by rice-field breeding Culex mosquitoes (van den Hurk et al., 2009; Unni et al., 
2011), especially Culex tritaeneorhynchus which is a species that breeds in paddy fields 
(Lindenbach & Rice, 2001). This suggests that most species of JE vectors are rural 
mosquitoes. In association with seasonal fluctuations in mosquito population densities, JE 
cases mostly appear during the summer, particularly May to October in most endemic areas 
(Rosen, 1986). In spite of this, other mosquitoes classified in different genera including 
Armigeres, Aedes, Anopheles, and Mansonia have also been documented to be a potential 
vector (Chen et al., 2000; Deng et al., 2009; Weng et al., 1999). 
The JE virion is about ca. 50 nm in diameter (Westaway et al., 1985); its genome contains 
linear, single-stranded positive-sense RNA (~11 kb in length) (Chambers et al., 1990). The 
genomic RNA of the JEV comprises a 5′ untranslated region (UTR), a longer 3′ UTR, and an 
intervening single open reading frame (ORF) (Chambers et al., 1990) that encodes 3 
structural proteins in the order of the capsid (C), membrane (prM/M), and envelope (E), 
followed by 7 non-structural proteins (NS1~NS5) (Chambers et al., 1990; Sumiyoshi et al., 
1987). The functions of some viral proteins are now clearer. Among these, protein E is the 
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major component of the viral envelope which binds to host cell surface receptors (Ren et al., 
2007) and is also involved in membrane fusion between the virion and host late endosomes 
(Stiasny & Heinz, 2006). NS3 is an enzyme with both serine protease and NTPase/helicase 
activities (Assenberg et al., 2009), while NS5 was confirmed to be a RNA-dependent RNA 
polymerase as well as a methyltransferase (Lescar & Canard, 2009; Zhou et al., 2007). 
 
 
Fig. 1. Transmission cycle of Japanese encephalitis virus in nature. A proportion of infected 
humans exhibit encephalitis and are a dead-end host after being bitten by infected 
mosquitoes 
In general, the JEV replicates inefficiently and thus causes delayed low-titer viremia in hosts 
(Shope & Sather, 1979). The central nervous system (CNS) is the principal target of infection 
by the JEV (Ravi et al., 1994). However, the virus is usually cleared from the CNS by an 
immune response before the development of encephalitis (McMinn et al., 1996). This thus 
leads to a relatively high number of subclinical infections in humans or those who rapidly 
recover from clinical symptoms, defined as a dead-end host (Mathur et al., 1987, Ravi et al., 
1994). It is estimated that about 1 in 25~1000 humans with infections, depending on the 
endemicity, exposure to mosquitoes, preexisting antibodies to flaviviruses, and viral strain 
differences (Mackenzie et al., 2004; Solomon and Vaughn, 2002), will exhibit clinical 
symptoms (Konishi & Suzuki, 2002). Despite this, the case fatality rate of JE can be as high as 
25%~30% (Burke & Leake, 1988); 15%~50% of the survivors may end up with sequelae of 
neurologic impairment and/or mental retardation (Monath, 2002). 
2. The route through which JEV enters the CNS 
The JEV tends to infect the CNS in dead-end hosts, i.e., humans (Johnson et al., 1985; 
Johnson, 1987). However, it is not clear how the virus gains entry into the CNS from the 
peripheral circulation (Myint et al., 2007). Theoretically, after the bite of an infected 
mosquito, the JEV is amplified in dermal tissues and then lymph nodes via migration of 
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dendritic (Langerhans) cells before invading the CNS (Johnson et al., 2000; Solomon et al., 
2000). A variety of flaviviruses were speculated to enter the CNS via the olfactory pathway 
(Monath et al., 1996), across cerebral capillary endothelial cells (Liou and Hsu, 1998), or 
virion budding on the parenchymal side after replication in endothelial cells (McMinn et al., 
1996). Nevertheless, features including the diffuse infection throughout the brain and no 
viral antigens in the choroid plexus or ependyma indicate that viruses probably enter the 
CNS via a hematogenous route (Kimura-Kuroda et al., 1992), especially with a status of 
severe viremia (Yamada et al., 2004). 
In both animals and humans, the blood-brain barrier (BBB) generally prevents viral invasion 
of the CNS (Ballabh et al., 2004), unless it has been disrupted, resulting in increased 
permeability and inflammatory cell infiltration (Muller et al., 2005). The BBB integrity was 
observed to evidently be weakened in the primary phase of JEV infection, showing modified 
distribution of occludin, a tight-junction (TJ) component protein of the BBB (Liu et al., 2008). 
Increased permeability of the BBB actually allows peripheral blood monocytes (PBMCs) to 
migrate from the peripheral blood into brain tissues (Stephens et al., 2003; Diamond & Klein, 
2004). Normally, lymphocytes constantly enter the CNS in small numbers (Hickey et al., 
1991), but their presence in the CNS may increase in response to viral infections (Griffin et 
al., 1992). 
PBMCs isolated from inoculated mice were detected to be infected by the JEV (Chuang et 
al., 2003; Liu et al., 2009). Leukocytes move across endothelial cells of capillaries at sites 
where TJs appear to be dissociated (Liu et al., 2008), suggesting that the JEV enters brain 
tissues via penetration of infected PBMCs. Uniquely, this pathway of penetration may begin 
at the cerebrum, not in the cerebellum (Liu et al., 2008). Destruction of the BBB can be 
caused by apoptosis of astrocytes and/or neurons (Suri & Banerjee, 1995; Tseng et al., 2011). 
Viral replication in peripheral tissues may also trigger a Toll-like receptor inflammatory 
response that alters the BBB (Wang et al., 2004). The stimulus capable of causing changes in 
BBB permeability can also be derived from the effects of the chemokine, monocyte 
chemoattractant protein (MCP)-1 (Stamatovic et al., 2005; Yamada et al., 2004). 
3. Pathogenesis of the JEV 
The JEV infects a variety of brain tissues with a characteristic pattern of mixed intensity of 
hypodense lesions in the thalamus, basal ganglia, and midbrain (Kalita & Misra, 2000, 2002). 
Most JE patients present typical clinical symptoms including headaches, vomiting, an 
altered mental state, as well as dystonia, rigidity, and a characteristic mask-like facies 
(Chuang et al., 2002). Clinically, movement disorders are frequently seen in patients who 
survive the acute phase of JE (Misra & Kalita, 1997), implying that sensorimotor neuropathy 
eventually occurs. It is now known that encphealitis associated with flaviviral infections 
may cause Guillain-Barré-like syndrome, showing a demyelinating feature in sensorimotor 
tissues of the brain (Sejvar et al., 2005). This suggests that demyelination is an important step 
causing disruption of motor coordination during JEV infection. 
The JEV has repeatedly been demonstrated to infect neurons in brains of experimental 
animals and humans (Johnson et al., 1985; Yamada et al., 2004) and is usually not cleared 
from tissues by elicited antibodies (Desai et al., 1995). Generally, encephalitic flaviviruses 
induce apoptosis in infected neurons and subsequently cause fatal outcomes to the host (Liu 
et al., 2008; Nargi-Aizenman & Griffin, 2001; Samuel et al., 2007; Xia et al, 2001). This 
possibly occurs by way of reactive oxygen specie-mediated induction of matrix 
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metalloproteinase-9 expression and subsequent activation of nuclear factor-κB (Tung et al., 
2010). Neuronal death, which is widely seen in JEV-infected mouse brains, is probably 
important for induction of axonal injury and demyelination (Meyer et al., 2001; Tsunoda et 
al., 2003). Demyelination is a common feature in brains infected with encephalitic viruses 
(Stohlman & Hinton, 2001); this is the process by which axons lose myelin that normally 
serves as an insulator, resulting in loss of balance and coordination, although it may vary 
among patients (Sarma, 2010). In fact, demyelination is rather common in mouse brains 
infected with the JEV; this is supposed to be triggered by T cell-mediated autoimmunity 
against the myelin basic protein (MBP), a component of myelin (Grigoriadis & 
Hadjigeorgiou, 2006; Tseng et al., 2011). In other words, the JEV, which normally causes 
inflammation and neuronal degeneration in the CNS, eventually induces the proliferation of 
specific T cells which mediate autoimmunity to destroy components of axon-surrounding 
myelin such as MBP (Tseng et al., 2011). 
4. Origin and genetic diversity of the JEV 
The first JE epidemic in history was reported in Japan in 1871 (van den Hurk et al., 2009); 
however, the causal virus was not isolated until 1935 (Rosen, 1986). There are 2 
epidemiological patterns of JE: one restrictedly occurs in tropical zones including South 
India, Indonesia, Malaysia, Singapore, and southern Thailand with no seasonal preference, 
and the other mainly occurs in northern parts of tropical zones, such as China, Taiwan, 
Japan, Korea, Nepal, and northern parts of Myanmar, India, and Viet Nam (Umenai et al., 
1985). The JEV in temperate areas is supposedly re-introduced by migratory birds or bats 
and/or is wind-borne (Rosen, 1986; Solomon et al., 2003). 
Phylogenic studies revealed that the JEV possesses genetic diversity among strains, through 
which the origin, evolution, and spread of the virus were theoretically determined (Gould, 
2002; Gould et al., 2004). It seems that the JEV originated from an ancestral virus in the 
Indonesia-Malaysia region, and subsequently evolved there into the different genotypes 
before they spread across Asia (Solomon et al., 2003). It was estimated that the ancestor 
common to all genotypes of JEV arose within the last 300 years (Uchil & Satchidanandam, 
2001). 
Major alterations in the genome of resulting viral variants frequently occur in the envelope 
(E) protein (Deubel et al., 1993; Trent et al., 1983, 1987). Based on the nucleotide sequences of 
the C/PrM and E genes, 5 genotypes (I~V) of the JEV were identified (fig. 2); these probably 
originated from the ancestral virus and evolved into the different genotypes (Solomon et al., 
2003). Geographically, genotype I includes isolates from Korea, India, Cambodia, Laos, and 
northern Thailand (Fan et al., 2010; Fulmali et al., 2011; Wang et al., 2007, 2010;); genotype II 
includes isolates from Malaysia, Sarawak, Indonesia, southern Thailand, and northern 
Australia (Pyke et al., 2001); genotype III includes isolates widely distributed in Asian 
countries with temperate climates, including Japan, Taiwan, China, India, Sri Lanka, Nepal, 
Viet Nam, and the Philippines (Chen et al., 1990; Mackenzie et al., 2004; Wang et al., 2007); 
and genotype IV includes isolates from Indonesia (Chen et al., 1992). The last one identified 
was genotype V, which includes isolates with a restricted distribution in India (Solomon et 
al., 2003; Uchil & Satchidanandam, 2001). Based on the composition of nucleotides and 
amino acids, strains belonging to genotype II are the most similar to genotype I (9.1%~10.7% 
difference), followed by genotype III (10.2%~11.7% difference), and genotype IV 
(16.2%~16.6% difference) (Schuh et al., 2011). The phylogenetic tree presented here shows 
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that genotype V is the most distant from genotype I. This newly identified genotype was 
suggested to have originated from Malaysia (Solomon et al., 2003). Nevertheless, it must be 
noted that the genetic similarity does not necessarily match their epidemiological 
distributions (Schuh et al., 2011). 
 
 
Fig. 2. Unrooted phylogenetic analysis of 17 homologs of protein E of the Japanese 
encephalitis virus showing that this protein can be divided into 5 clades or genotypes. 
Genotype I: K91P55 (U34928), M859 (U70410), P19Br (U70416), K94P05 (AF045551), and 
ThCMAr4492 (D45362); genotype II: B1065 (U70388), FU (AF217620), JKT5441 (U70406), and 
JKT1749 (U70405); genotype III: RP-9 (AF014161), GP78 (AF075723), SA-14-2-8 (U15763), 
JaOArS982 (M18370), Beijing-1 (L48961), Nakayama (EF571853), and TL (AF098737); 
genotype IV: JKT7003 (U70408), JKT6468 (AY184212), and JKT9092 (U70409); and genotype 
V: Muar (HM596272). The analysis used the Neighbor-joining method within the PHYLIP 
3.6 software package with 500 bootstraps (Felsenstein, 2005) after sequence alignment with 
the Clustal W package (Thompson et al., 1994) 
In fact, intra-genotypic groupings can occur (Ali & Igarashi, 1997; Wang et al., 2007), among 
which genotypes IV and V are the most divergent genotypes and are thought to represent 
the oldest lineages (Misra & Kalita, 2010). Genotype III can further be divided into 3 clusters 
among strains isolated in Taiwan (Huang et al., 2010). It is interesting that genotype III was 
the major one in Japan before 1991, while most isolates after 1995 were identified as 
belonging to genotype I (Ma et al., 2003; Morita, 2009). A similar phenomenon or even 
genotype replacement was also seen in many other countries in Asia (Huang et al., 2010; 
Morita, 2009; Nitatpathana et al., 2008). This suggests that the flow or a shift of genotypes 
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between endemic regions is possible (fig. 3). Eventually, genotype I, which is genetically 
close to those from Malaysia, was found to have been introduced and co-circulated with 
and/or ultimately replaced the existing genotype III in many Asian countries (Fulmali et al., 
2011; Huang et al., 2010; Ma et al., 2003; Nga et al., 2004; Pyke et al., 2001; Wang et al., 2007; 
Yoshida et al., 2005; Yun et al., 2010). Putatively, the introduced genotype I originated from 
Southeast Asia (Nabeshima et al., 2009; Nga et al., 2004); which has been an important 
region for emerging pathogens (Solomon et al., 2003). Wind-blown infected mosquitoes 
flying with air currents during the typhoon season supposedly played a role in the 
geographic expansion (Ritchie & Rochester, 2001). 
 
 
Fig. 3. Japanese encephalitis virus (JEV) is widely distributed in most Asian countries (gray). 
Among the 5 genotypes of JEV, genotype III (blue) has been predominant in most northeast 
Asian countries such as Taiwan, China, Japan, Korea, Viet Nam, Thailand, and even India. 
Genotype I (green) was putatively introduced by wind-blown infected mosquitoes, for 
example, during the typhoon season. Nowadays, the mixed occurrence of both genotypes 
(orange) has become common in such regions 
5. Mutations and evolution of the JEV in nature 
RNA genomes of flaviviruses evolve rather rapidly compared to DNA-based organisms. 
Generally, RNA viruses evolve rapidly, with approximately 6 orders of magnitude higher 
rates of nucleotide substitutions compared to DNA viruses (Jenkins et al., 2002). It seems 
that horizontal gene transfer of the virus between host cells increases its genetic diversity. 
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Therefore, it is important to see how genetic diversity occurs, either by investigating the 
molecular epidemiology or evolution of flaviviruses. Unlike re-assortments of RNA 
segments that frequently occur in the influenza virus (Khiabanian et al., 2009), flaviviruses 
readily change nucleotides in their genomes due to a lack of proof-reading and mismatch 
repair abilities (Holland, 1996). This error-prone nature of RNA synthesis triggers mutations 
which are an important source of RNA virus diversity. They, in turn, form a variety of 
genetically related variants known as “quasispecies” and are responsible for the 
pathogenesis and tissue distribution of viruses (Holmes, 2004). 
Natural mutations with lower virulence were isolated from field-caught mosquitoes (Chiou & 
Chen, 2001), leading to circulation in a human population with a low incidence of the disease 
(Chen et al., 2000). Among most viruses, mutations serve as the major source of genetic 
change; which in turn creates strains that may be either lethal or advantageous. The E protein 
is known to be the major component on the surface of flaviviral virions (Adams et al., 1995; 
Rey et al., 1995), and generally plays a role in interactions with molecule(s) or receptor(s) on 
cell membranes when the virus infects host cells (Martinez-Barragan & del Angel, 2001; 
Ramos-Castaneda et al., 1997; Rothwell et al., 1996). Passage of flaviviruses in cultured cells 
was demonstrated to induce genetic changes in the E protein (Marchette et al., 1990), causing 
phenotypic alterations, e.g., viral virulence (Cao et al., 1995; Hasegawa et al., 1992). 
As mentioned, phenotypic changes may be caused by mutations in the E protein (fig. 4), 
which include antigenicity, pathogenicity, virulence, persistence, or interactions with host 
cells (Cecilia & Gould, 1991; Chiou et al., 2007; Chung et al., 1996; Hasegawa et al., 1994; Lee 
& Lobigs, 2002; Mangada & Takegami, 1999; Ni & Barrett, 1996; Nitayaphan et al., 1990; Wu 
et al., 1998). It was reported that a single mutation at E-123 (Ser→Arg) in the JEV 
significantly increases the virulence in mice, indicating that this nucleotide may be 
responsible for the pathogenicity of the JEV (Tajima et al., 2010). In Neuro-2a cells, a higher-
virulent variant (CJN-S1) of the JEV with a mutation at E-138 (Glu→Lys) was isolated from 
human brain tissues in a relatively short time of passage. The same mutation was also 
reported to evidently affect multiple steps of the life cycle of the JEV (Zhao et al., 2005), 
including reduced neurotropism and attenuated virulence (Chen et al., 1996; Ni & Barrett, 
1998). The specific step of such an effect is its ability to attach and penetrate (Liu et al., 2004), 
leading to lower virulence in host cells (Chiou & Chen, 2007). In the meantime, mutations at 
E-306 (Glu→Lys) (T1P1-S1) and E-389 (Asp→Asn) (CC27-S6) were also observed to possess 
a higher affinity for heparin sulfate and to form small plaques (Chiou et al., 2005). 
Apparently, the E protein is not the only site of the viral genome related to phenotype 
determination of the JEV. A single N-linked glycosylation site in the prM protein of the JEV 
was documented to be critical for the pathogenicity of the virus in mice (Kim et al., 2008). 
Factors affecting the genetic diversity of the JEV may be complex and remain to be worked 
out. In a study of E/NS1 protein of another flavivirus (dengue), the genetic composition 
changed with passages of cultured cells (Chen et al., 2003). In fact, 1  (E-53) and 2 amino 
acids (NS1-178 and NS1-181) had mutated after 30 passages in Vero cells, while no changes 
were observed in viruses serially passaged in C6/36 cells (Chen et al., 2003). This reflects a 
feature by which mutations occur more slowly in arboviruses, either alphaviruses or 
flaviviruses, than in other RNA viruses (Weaver et al., 1992). Perhaps, antioxidant defenses 
that protect mosquito cells from apoptosis in response to the virus may play an important 
role in reducing the occurrence of viral mutations (Chen et al., 2011). 
Heparan sulfate, a glycosaminoglycan (GAG), on the surface of all adherent cells is known 
to modulate the actions of a number of extracellular ligands (Bernfield et al., 1999). Clusters 
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consisting of E protein residues 49, 138, 306, or 389/390 on the surface of JE virions may 
define molecular determinants for GAG binding and concomitant virulence attenuation in 
human adenocarcinoma (SW13) cells (Lee et al., 2004). Additionally, the JEV strain with the 
mutation of Glu-306-Lys in the E protein was found to increase its binding ability with 
highly sulfated forms of GAGs in Neuro-2a cells (Chiou et al., 2005). This implies that 
GAGs, particularly highly sulfated forms (Su et al., 2001), in host cells can be important as a 
tool to screen viral strains (Chiou et al., 2005). 
 
 
Fig. 4. Phenotypic changes through mutations in the E protein may determine viral 
characteristics, such as the antigenicity, pathogenicity, virulence, persistence, and 
interactions with host cells. Several amino acids, including E123, E138, E306, and E389, were 
demonstrated to be important in the ability of the Japanese encephalitis virus to interact 
with a host 
Viral evolution generally occurs as a result of genetic variations and selection of variants 
from large viral populations, producing a new genetic makeup which can pass from 
generation to the next. Due to the differential fates of flaviviruses in vertebrate and 
mosquito cells (Chen et al., 2003), patterns of genetic evolution may differ between viruses 
replicating in these 2 types of host cells. Experimental evidence showed that slower 
mutations of arboviruses, either alphaviruses or flaviviruses, may occur in mosquito cells by 
applying the brake on the evolution of these viruses (Vasilakis et al., 2009). The evolution of 
viruses depends on the mutation-selection balance. It was hypothesized that the JEV 
changes its genetic composition under certain circumstances in vertebrate cells. In contrast, 
either positive or negative selection can occur in mosquito cells, selecting fitter variants. 
6. RNA recombination in the JEV 
As mentioned, RNA viruses evolve rapidly compared to DNA viruses, with approximately 
6 orders of magnitude higher rates of nucleotide substitutions (Jenkins et al., 2002). In 
addition, genetic exchanges via re-assortment of RNA segments are known to occur in 
segmented RNA-containing viruses such as the influenza virus (Khiabanian et al., 2009), 
rotavirus (Gentsch et al., 2005), bluetongue virus (Carpi et al., 2010), and so forth. RNA 
recombinations are now believed to be one mechanism exploited by many viruses, which 
serve as a strategy for evolution (Worobey & Holmes, 1999). This was found in the 
poliovirus (Ledinko, 1963), flaviviruses (Cristina & Colina, 2006; Twiddy & Holmes, 2003), 
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and others (Rohayem et al., 2005). Most notably, western equine encephalitis virus, a 
member of the genus Alphavirus, is thought to have originated from a recombination 
between an eastern equine encephalitis-like virus and a Sindbis-like virus, giving rise to a 
completely new virus (Hahn et al., 1988). Similarly, the Singapore S275/90 strain of dengue 
1 virus very likely arose from a recombination between a Djibouti/Cambodia lineage 
ancestor and an Abidjan lineage ancestor (Tolou et al., 2001). 
Genetic diversity derived from spontaneous mutations and the introduction of new strains 
through migratory birds increase the possibility of RNA recombination in the JEV (Rosen, 
1986). Accumulating data from phylogenetic analyses indicate that the recombinant forms of 
the JEV may have appeared in Korea and Thailand (Twiddy & Holmes, 2003). It is now 
believed that 2 putative recombinants isolated from Korea (K82P01 and K91P55) appear to 
have parental strains originating in Japan and Korea, while one from Thailand (Thailand 82) 
has parental strains originating in Thailand and China (Twiddy & Holmes, 2003). 
 
 
Fig. 5. Two possible mechanisms were proposed for the occurrence of RNA recombination: 
(i) the copy choice mechanism and (ii) breakage and rejoining (Lai, 1992) 
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In general, recombination follows 2 possible mechanisms (fig. 5): (1) a copy choice 
mechanism and (2) breakage and rejoining (Lai, 1992). The breaking and rejoining pathway 
is commonly seen with DNA but usually not with RNA recombinations (Jarvis & 
Kirkegaard, 1991, 1992). In contrast, a copy choice mechanism for RNA recombination was 
demonstrated to occur in the poliovirus; in which templates are switched by viral RNA-
dependent RNA polymerase (RdRp) switches during negative-strand synthesis (Kirkegaard 
& Baltimore, 1986). This may also be the mechanism of RNA recombination in other RNA 
viruses such as coronaviruses and plant viruses (Makino et al., 1986; Sztuba-Solunsk et al., 
2011). 
There are 3 types of RNA recombinations (fig. 6), including precisely homologous, 
imprecisely (aberrantly) homologous, and non-homologous, which are known to occur in 
RNA viruses (Alejska et al., 2001). Of these, the precisely homologous recombination 
through a template-switching (copy-choice) mechanism is probably the most common type 
(Wierzchoslawski & Bujarski, 2006). We recently provided experimental evidence showing 
that genetically different JEV strains can simultaneously infect a single BHK-21 or C6/36 
cell, resulting in the occurrence of genetic exchange or RNA recombination. It probably 
follows the copy choice mechanism with the precisely homologous recombination type 
(Chuang & Chen, 2009). 
Secondary structures are probably essential for the occurrence of RNA (Hsue et al., 2000; 
Wierzchoslawski & Bujarski, 2006). It is particularly important that the structure of the 
acceptor RNA affects the occurrence of RNA recombinations in the case of HIV (Abdeladim 
et al., 2003). The stability of the secondary structure eventually promotes the frequency of 
template-switching RNA recombinations (Nagy & Jozef, 1997; White & Morris, 1995). In the 
JEV, changes in specific secondary structures eventually affect the frequency of RNA 
recombinations (Chuang & Chen, 2009). 
Recently, AU-rich sequences were mentioned as being more efficient at promoting 
recombination, compared to GC-rich sequences, in single-stranded, positive-sense genomic 
RNA (Shapka & Nagy, 2004). However, AU-rich sequences do not really exist, and the AU 
content was < 50% in the region favoring crossovers in Japanese encephalitis according our 
recent study (Chuang & Chen, 2009). Perhaps the nucleotide composition of the sequence is 
not crucial in determining RNA recombinations of the JEV. Because neither deletions nor 
insertions of nucleotides were shown to occur in the crossover region, the precisely 
homologous recombination is believed to be the predominant, if not the only, type of RNA 
recombination between JEVs. This is consistent with the inference from previous 
observations that AU-rich sequences usually decrease the accuracy of crossovers, leading to 
imprecisely or aberrantly homologous recombinations of viral RNA (Nagy & Bujarski, 
1996). 
Rates of recombination in many single-stranded RNA viruses appear to be low (Chare et al., 
2006; Worobey & Holmes, 1999), and RNA recombination is thought to have played some 
roles in the co-evolution of viruses with genetic conflicts (Turner & Chao, 1998) and the 
development of strains with increased virulence and transmission potential (Holmes et al., 
1999). Moreover, RNA recombination was found more frequently in BHK-21 than C6/36 
cells, indicating that mammalian cells are more crucial in determining RNA 
recombinations (Schneider & Roossinch, 2001). This causes higher rates of genetic variants 
in mammalian cells, and only those with fitness are selected, which possibly also operates 
in mosquito cells. 
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Fig. 6. Putatively, there are 3 types of RNA recombinations: (i) homologous (precisely), (ii) 
aberrantly (imprecise) homologous, and (iii) non-homologous (Alejska et al., 2001) 
7. Conclusions and perspectives 
Because of underlying mutation and genetic recombinations, the JEV probably evolves in a 
very similar way to that which governs other organisms. Nowadays, new mass-sequencing 
techniques are more popular and have revealed a greater diversity of flaviviruses than ever 
thought (Kuno et al., 1998). Due to the small size and probably the fragility, virus evolution 
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cannot possibly be investigated from so-called fossil viruses, if there are any. However, 
genetic diversity in nature provides information, facilitating an understanding of the 
existence of viral evolution. Maintenance of genetic diversity can theoretically reduce the 
rapid loss of fitness due to Muller’s ratchet during passage of the virus from 1 host to 
another. Evolutionary, this is beneficial for a virus that has shifted to a new environmental 
niche or selective regimen, serving as a factor helping a virus escape from accumulated 
deleterious effects in a virus population. 
Most flaviviruses comprise multiple genotypes or strains which potentially determine the 
virulence and epidemiology of the diseases. Mutation(s) of the viral genome followed by 
selection in host cells are the commonest way to form a new viral strain, the phenotypes of 
which may be more virulent or attenuated. Understanding changes in genomic RNA can 
help better elucidate evolving viruses as well as their clinical significance. Accumulating 
evidence suggests that RNA recombination is also one mechanism creating diversity of 
viruses, producing more unpredictable results during their evolution. A special concern is 
the possibility of genetic exchange between different populations of the virus (Tolou et al., 
2001). As a result, it is particularly worthwhile noting whether or not live-attenuated vaccine 
strains experience crossing-over with wild viruses during the synthesis of new RNA (Becher 
et al., 2001; Holmes et al., 1999). 
8. Acknowledgment 
This work was financial supported by National Science Council of Taiwan (NSC99-2320-B-
182-012-MY3) and partially by Chang Gung Memorial Hospital (CMRPD190161). The 
authors would like to thank Mr. Wei-Ting Chen for figure sketching. 
9. References 
Abdeladim, M.; Lucette, P.; Torsten, U.; Michel, V.; Henri, B. & Matteo, N. (2003). Evidence 
for a mechanism of recombination during reverse transcription dependent on the 
structure of the acceptor RNA. Journal of Biological Chemistry, 278, pp. 15973-15982. 
Adams, S. C.; Broom, A. K.; Sammels, L. M.; Hartnett, A. C.; Howard, M. J.; Coelen, R. J.; 
Mackenzie, J. S. & Hall, R. A. (1995). Glycosylation and antigenic variation among 
Kunjin virus isolates. Virology, 206, pp. 49-56. 
Alejska, M.; Kurzyñska-Kokorniak, A.; Broda, M.; Kierzek, R. & Figlerowicz, M. (2001) How 
RNA viruses exchange their genetic material. Acta Biochimic. Polonica, 48, pp. 391-
407. 
Ali, A. & Igarashi, A. (1997). Antigenic and genetic variations among Japanese encephalitis 
virus strains belonging to genotype 1. Microbiology and Immunology, 41, pp. 241-52. 
Assenberg, R.; Mastrangelo, E.; Walter, T. S.; Verma, A.; Milani, M.; Owens, R. J.; Stuart, D. 
I.; Grimes, J. M. & Mancini, E. J. (2009). Crystal structure of a novel conformational 
state of the flavivirus NS3 protein: implications for polyprotein processing and 
viral replication. Journal of Virology, 83, pp. 12895-12906. 
Ballabh, P.; Braun, A. & Nedergaard, M. (2004). The blood-brain barrier: an overview: 
structure, regulation, and clinical implications. Neurobiology of Disease, 16, pp. 1-13. 
Becher, P.; Orlich, M. & Thiel, H. J. (2001). RNA recombination between persisting pestivirus 
and a vaccine strain: generation of cytopathogenic virus and induction of lethal 
disease. Journal of Virology, 75, pp. 6256-6264. 
www.intechopen.com
 
Genetic Evolution of Japanese Encephalitis Virus 
 
395 
Bernfield, M.; Götte, M.; Park, P. W.; Reizes, O.; Fitzgerald, M. L.; Lincecum, J. & Zako, M. 
(1999). Functions of cell surface heparan sulfate proteoglycans. Annual Review of 
Biochemistry, 68, pp. 729-777. 
Burke, D.S. & Leake, C. J. (1988). Japanese encephalitis, In: The Arboviruses: Epidemiology and 
Ecology, T. P. Monath, (Ed.), 63-92, CRC, Boca Raton, Florida, USA. 
Cao, J. X.; Ni, H.; Wills, M. R.; Campbell, G. A.; Sil, B. K.; Ryman, K. D.; Kitchen, I. & Barrett, 
A. D. (1995). Passage of Japanese encephalitis virus in HeLa cells results in 
attentuation of virulence in mice. Journal of General Virology, 76, pp. 2757-2764. 
Carpi, G.; Holmes, E. C. & Kitchen, A. (2010). The evolutionary dynamics of bluetongue 
Virus. Journal of Molecular Evolution, 70, pp. 583-592. 
Cecilia, D. & Gould, E. A. (1991). Nucleotide changes responsible for loss of 
neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. 
Virology, 181, pp. 70-77. 
Chambers, T. J.; Hahn, C. S.; Galler, R. & Rice, C. M. (1990). Flavivirus genome organization, 
expression, and replication. Annual Review of Microbiology, 44, pp. 649-688. 
Chare, E. R. & Holmes, E. C. (2006). A phylogenetic survey of recombination frequency in 
plant RNA viruses. Archive of Virology, 151, pp. 933-946. 
Chen, L. K.; Lin, Y. L.; Liao, C. L.; Lin, C. G.; Huang, Y. L.; Yeh, C. T.; Lai, S. C.; Jan, J. T. & 
Chin, C. (1996). Generation and characterization of orang-tropism mutants of 
Japanese encephalitis in vivo and in vitro. Virology, 223, pp. 79-88. 
Chen, T. H.; Tang, P.; Yang, C. F.; Kao, L. H.; Lo, Y. P.; Chuang, C. K.; Shih, Y. T. & Chen, W. 
J. (2011). Antioxidant defense is one of the mechanisms by which mosquito cells 
survive dengue 2 viral infection. Virology, 410, pp. 410-417. 
Chen, W. J.; Wu, H. R. & Chiou, S. S. (2003). E/NS1 modifications of dengue 2 virus after 
serial passages in mammalian and/or mosquito cells. Intervirology, 46, pp. 289-295. 
Chen, W. J.; Dong, C. F.; Chiou, L. Y. & Chuang, W. L. (2000). Potential role of Armigeres 
subalbatus (Diptera: Culicidae) in the transmission of Japanese encephalitis virus in 
the absence of rice culture on Liu-Chiu Islet, Taiwan. Journal of Medical Entomology, 
37, pp. 108-113. 
Chen, W. R.; Rico-Hesse, R. & Tesh, R. B. (1992). A new Genotype of Japanese Encephalitis 
Virus from Indonesia. American Journal of Tropical Medicine and Hygiene, 47, pp. 61-
69. 
Chen, W. R.; Tesh, R. B. & Rico-Hesse, R. (1990). Genetic variation of Japanese encephalitis 
virus in nature. Journal of General Virology, 71, pp. 2915-2922. 
Chiou, S. S. & Chen, W. J. (2001). Mutations in the NS3 gene and 3’-NCR of Japanese 
encephalitis virus isolated from an unconventional ecosystem and implications for 
natural attenuation of the virus. Virology, 289, pp. 129-136. 
Chiou, S. S. & Chen, W. J. (2007). Phenotypic changes in the Japanese encephalitis virus after 
one passage in Neuro-2a cells: Generation of attenuated strains of the virus. 
Vaccine, 26, pp. 15-23.  
Chiou, S. S.; Liu, H.; Chuang, C. K.; Lin, C. C. & Chen, W. J. (2005). Fitness of Japanese 
encephalitis virus to Neuro-2a cells is determined by interactions of viral envelope 
protein with highly sulfated glycosaminoglycans on the cell surface. Journal of 
Medical Virology, 76, 2005, 583-592. 
www.intechopen.com
  
Flavivirus Encephalitis 
 
396 
Chiou, S. S.; Tsai, K. H.; Huang, C. G.; Liao, Y. K. & Chen, W. J. (2007). High antibody 
prevalence in an unconventional ecosystem is related to circulation of a low-
virulent strain of Japanese encephalitis virus. Vaccine, 25, pp. 1437-1443. 
Chuang, C. K. & Chen, W. J. (2009). Experimental evidence that RNA recombination occurs 
in the Japanese encephalitis virus. Virology, 394, pp. 186-197. 
Chuang, C. K.; Chiou, S. S.; Liang, L. C. & Chen, W. J. (2003). Detection of Japanese 
encephalitis virus inside peripheral blood mononuclear cells of mouse using in situ 
RT-PCR. American Journal of Tropical Medicine and Hygiene, 69, pp. 648-651. 
Chuang, Y. M.; Kwan, S. Y.; Lirng, J. F.; Tiu, C. M. & Pan, P. J. (2002). Radiological and 
manometric diagnosis of cricopharyngeal dysphagia in a Japanese encephalitis 
survivor. European Journal of Neurology, 9, pp. 407−411. 
Chung, Y. J.; Nam, J. H.; Ban, S. L. & Cho, H. W. (1996). Antigenic and genetic analysis of 
Japanese encephalitis viruses isolated from Korea. American Journal of Tropical 
Medicine and Hygiene, 55, pp. 91-97. 
Cristina, J. & Colina, R. (2006). Evidence of structural genomic region recombination in 
hepatitis C virus. Virology Journal, 3, pp. 53. 
Deng, S.; Zhang, H. & Li, J. (2009). Distribution characteristics of mosquitoes and their 
natural infection with Japanese encephalitis virus in Yunnan province. Chinese 
Journal of Vector Biology and Control, 20, pp. 344-348. 
Desai, A.; Shankar, S. K.; Chandramuki, A. & Gourie-Devi, M. (1995). Japanese encephalitis 
virus antigen in the human brain and its topographic distribution. Acta 
Neuropathologica, (Berl.) 89, pp. 368-73. 
Deubel, V.; Nogueira, M.; Drouet, M. T.; Zeller, H.; Reynes, J. M. & Do, Q. H. (1993). Direct 
sequencing of genomic cDNA fragments amplified by the polymerase chain 
reaction for molecular epidemiology of dengue 2 viruses. Archive of Virology, 129, 
pp. 197-210. 
Diamond, S. M., & Klein, R. S. (2004). West Nile virus: crossing the blood-brain barrier. 
Nature Medicine, 10, pp. 1294-1295. 
Erlanger, T. E.; Weiss, S.; Keiser, J.; Utzinger, J. & Wiedenmayer, K. (2009). Past, present, and 
future of Japanese encephalitis. Emerging Infectious Diseases, 15, pp. 1-7. 
Fan, J. M.; Luo, J.; Chen, L.; Teng, M.; Bu, D.; Wang, F. Y.; Wang, L.; Wang, C. Q. & Zhang, 
G. P. (2010). Genetic analysis of strains of Japanese encephalitis virus isolated from 
swine in central China. Virus Gene, 40, pp. 357–361. 
Felsenstein, J. (2005). PHYLIP (Phylogeny Inference Package) version 3.6: Department of 
Genome Science, University of Washington, Seattle, USA. 
Fulmali, P. V.; Sapkal, G. N.; Athawale, S.; Gore, M. M.; Mishra, A. C. & Bondre, V. P. (2011). 
Introduction of Japanese encephalitis virus genotype I, India. Emerging Infectious 
Diseases, 17, pp. 319-321. 
Gentsch, J. R.; Laird, A. R.; Bielfelt, B.; Griffin, D. D.; Banyaim, K.; Ramachandran, M.; Jain, 
V.; Cunliffe, N. A.; Nakagomi, O.; Kirkwood, C. D.; Fischer, T. K.; Parashar, U. D.; 
Bresee, J. S.; Jiang, B. & Glass, R. I. (2005). Serotype diversity and reassortment 
between human and animal rotavirus strains: implications for rotavirus vaccine 
programs. Journal of Infectious Diseases, 192 (Suppl 1), pp. S146-S159. 
Gould, E. A. (2002). Evolution of Japanese encephalitis serocomplex viruses. Curr. Top. 
Microbiology and Immunology, 267, pp. 391-404. 
www.intechopen.com
 
Genetic Evolution of Japanese Encephalitis Virus 
 
397 
Gould, E. A.; Moss, S. R. & Turner, S. L. (2004). Evolution and dispersal of encephalitic 
flavivruses. Archive of Virology, (Suppl.) 18, pp. 65-84. 
Griffin, D. E.; Levine, B.; Tyor, W. R. & Irani, D. N. (1992). The immune response in viral 
encephalitis. Seminars in Immunology, 4, pp. 111-119. 
Grigoriadis, N. & Hadjigeorgiou, G. M. (2006). Virus-mediated autoimmunity in multiple 
sclerosis. Journal of Autoimmune Diseases, 3, pp. 1. 
Hahn, C.S.; Lustig, S.; Strauss, E. G. & Strauss, J. H. (1988). Western equine encephalitis virus 
is a recombinant virus. Proceedings of the National Academy of Sciences, 85, pp. 5997-
6001. 
Hasegawa, H.; Yoshida, M.; Fujita, S. & Kobayashi, Y. (1994). Comparison of structural 
proteins among antigenically different Japanese encephalitis virus strains. Vaccine, 
12, pp. 841-844. 
Hasegawa, H.; Yoshida, M.; Shiosaka, T.; Fujita, S. & Kobayashi, Y. (1992). Mutations in the 
envelope protein of Japanese encephalitis virus affect entry into cultured cells and 
virulence in mice. Virology, 191, pp. 158-165. 
Hickey, W. F.; Hsu, B. L. & Kimura, H. (1991). T-lymphocyte entry into the central nervous 
system. Journal of Neuroscience Research, 28, pp. 254-260. 
Holland, J. J. (1996). Evolving virus plaques. Proceedings of the National Academy of Sciences, 
93, pp. 545-546. 
Holland, J.; Spindler, K.; Horodyski, F.; Grabau, E.; Nichol, S. & VandePol, S. (1982). Rapid 
evolution of RNA genomes. Science, 215, pp. 1577-1585. 
Holmes, E. C. (2004). The phylogeography of human viruses. Molecular Ecology, 13, pp. 745-
756. 
Holmes, E. C.; Worobey, M., & Rambaut, A. (1999). Phylogenetic evidence for recombination 
in dengue virus. Molecular Biology and Evolution, 16, pp. 405-409. 
Hsue, B.; Hartshorne, T. & Masters, P. S. (2000). Characterization of an essential RNA 
secondary structure in the 3′ untranslated region of the murine coronavirus 
genome. Journal of Virology, 74, pp. 6911-6921. 
Huang, J. H.; Lin, T. H.; Teng, H. J.; Su, C. L.; Tsai, K. H.; Lu, L. C.; Lin, C.; Yang, C. F.; 
Chang, S. F.; Liao, T. L.; Yu, S. K.; Cheng, C. H.; Chang, M. C.; Hu, H, C. & Shu, P. 
Y. (2010). Molecular epidemiology of Japanese encephalitis virus, Taiwan. Emerging 
Infectious Diseases, 16, pp. 876-878. 
Jarvis, T. C. & Kirkegaard, K. (1991). The polymerase in its labyrinth: mechanisms and 
implications of RNA recombination. Trends in Genetics, 7, pp. 186-191. 
Jarvis, T. C. & Kirkegaard, K. (1992). Poliovirus RNA recombination: mechanistic studies in 
the absence of selection. EMBO Journal, 11, pp. 3135-3145. 
Jenkins, G. M.; Rambaut, A.; Pybus, O. G. & Holmes, E. C. (2002). Rates of molecular 
evolution in RNA viruses: a quantitative phylogenetic analysis. Journal of Moleculaar 
Evolution, 54, pp. 152-161. 
Johnson, L. J.; Halliday, G. M. & King, N. J. (2000). Langerhans cells migrate to local lymph 
nodes following cutaneous infection with an arbovirus. Journal of Investigative 
Dermatology 114, pp. 560-568. 
Johnson, R. T. (1987).The pathogenesis of acute viral encephalitis and postinfectious 
encephalomyelitis. Journal of Infectious Diseases, 155, pp. 359-364. 
www.intechopen.com
  
Flavivirus Encephalitis 
 
398 
Johnson, R. T.; Burke, D. S.; Elwell, M.; Leake, C. J.; Nisalak, A.; Hoke, C. H. & Lorsomrudee, 
W. (1985). Japanese encephalitis: Immunocytochemical studies of viral antigen and 
inflammatory cells in fatal cases. Annals of Neurology, 18, pp. 567-573. 
Kalita, J. & Misra, U. K. (2000). Comparison of CT and MRI findings in the diagnosis of 
Japanese encephalitis. Journal of Neurological Science, 174, pp. 3-8. 
Kalita, J. & Misra, U. K. (2000). Neurophysiological changes in Japanese encephalitis. 
Neurology India, 50, pp. 262-266. 
Khiabanian, H.; Trifonov, V. & Rabadan, R. (2009). Reassortment patterns in swine influenza 
viruses. PLoS ONE, 4, pp. e7366. 
Kim, J. M.;Yun, S. I.; Song, B. H.; Hahn, Y. S.; Lee, C. H.; Oh, H. W. & Lee, Y. M. (2008).A 
single N-linked glycosylation site in the Japanese encephalitis virus prM protein is 
critical for cell type-specific prM protein biogenesis, virus particle release, and 
pathogenicity in mice. Journal of Virology, 82, pp. 7846-7862. 
Kimura-Kuroda, J.; Ichikawa, M.; Ogata, A.; Nagashima, K.; Yasui, K. (1992). Specific 
tropism of Japanese encephalitis virus for developing neurons in primary rat brain 
culture. Archive of Virology, 130, pp. 477-484. 
Kirkegaard, K. & Baltimore, D. (1986). The mechanism of RNA recombination in poliovirus. 
Cell, 47, pp. 433-443. 
Konishi, E. & Suzuki, T. (2002). Ratios of subclinical to clinical Japanese encephalitis (JE) 
virus infections in vaccinated populations: evaluation of an inactivated JE vaccine 
by comparing the ratios with those in unvaccinated populations. Vaccine, 21, pp. 98-
107. 
Kuno, G.; Chang, G. J.; Tsuchiya, K. R.; Karabatsos, N. & Cropp, C. B. (1998). Phylogeny of 
the genus Flavivirus. Journal of Virology, 72, pp. 73-83. 
Lai, M. M. (1992). RNA recombination in animal and plant viruses. Micribiology and 
Molecular Biology Review, 56, pp. 61-79. 
Ledinko, N. (1963).Genetic recombination with poliovirus type 1: studies of crosses between 
a normal horse serum-resistant mutant and several guanidine-resistant mutants of 
the same strain. Virology, 20, pp. 107-119. 
Lee, E. & Lobigs, M. (2002). Mechanism of virulence attenuation of glycosaminoglycans-
binding variants of Japanese encephalitis virus and Murray Valley encephalitis 
Virus. Journal of Virology, 76, pp. 4901-4911. 
Lee, E.; Hall, R. A. & Lobigs, M. (2004). Common E protein determinants for attenuation of 
glycosaminoglycan-binding variants of Japanese encephalitis and West Nile 
viruses. Journal of Virology, 78, pp. 8271-8280. 
Lescar, J. & Canard, B. (2009). RNA-dependent RNA polymerases from flaviviruses and 
Picornaviridae. Current Opinion in Structural Biology, 19, pp. 759-767. 
Lindenbach, B. D. & Rice, C. M. (2001). Flaviviridae: the viruses and their replication, In: 
Fields Virology, vol. 1. 4th ed, D. M. Knipe & P. M. Howley, (Eds.), 991-1041. 
Lippincott Williams & Wilkins Publishers, Philadelphia, PA, USA. 
Liou, M. L. & Hsu, C. Y. (1998). Japanese encephalitis virus is transported across the cerebral 
blood vessels by endocytosis in mouse brain. Cell and Tissue Research, 293, pp. 389-
394. 
Liu, H.; Chiou, S. S. & Chen, W. J. (2004). Differential binding efficiency between the 
envelope protein of Japanese encephalitis virus variants with heparan sulfate on 
the cell surface. Journal of Medical Virology, 72, pp. 618-624. 
www.intechopen.com
 
Genetic Evolution of Japanese Encephalitis Virus 
 
399 
Liu, T. H.; Liang, L. C.; Wang, C. C.; Liu, H. C. & Chen, W. J. (2008). The blood-brain barrier 
in the cerebrum is the initial site for the Japanese encephalitis virus entering the 
central nervous system. Journal of Neurovirology, 14, pp. 514-521. 
Liu, Y.; Chuang, C. K. & Chen, W. J. (2009). In situ reverse-transcription loop-mediated 
isothermal amplification (in situ RT-LAMP) for detection of Japanese encephalitis 
viral RNA in host cells. Journal of Clinical Virology, 46, pp. 49-54. 
Ma, S. P.; Yoshida, Y.; Makino, Y.; Tadano, M.; Ono, T. & Ogawa, M. (2003). A major 
genotype of Japanese encephalitis virus currently circulating in Japan. American 
Journal of Tropical Medicine and Hygiene, 69, pp. 151-154.  
Mackenzie, J. S. (1999). Emerging viral diseases: an Australian perspective. Emerging 
Infectious Diseases, 5, pp.1-8.  
Mackenzie, J. S.; Gubler, D. J. & Petersen, L. R. (2004). Emerging flaviviruses: the spread and 
resurgence of Japanese encephalitis, West Nile and dengue viruses. Nature 
Medicine, 10, pp. S98-S109. 
Mackenzie, J. S.; Williams, D. T. & Smith, D. W. (2007). Japanese encephalitis virus: the 
geographic distribution, incidence, and spread of a virus with a propensity to 
emerge in new areas. In: Emerging viruses in human populations, E. Tabor, (Ed.), 201-
268, Elsevier, Amsterdam, Netherlands. 
Mangada, M. N. M. & Takegami, T. (1999). Molecular characterization of the Japanese 
encephalitis virus representative immunotype strain JaGAr 01. Virus Research, 59, 
pp. 101-112. 
Marchette, N. J.; Dubois, D. R.; Larsen, L. K.; Summers, P. L.; Kraiselburd, E. G.; Gubler, D. J. 
& Eckels, K. H. (1990). Preparation of an attenuated dengue 4 (341750 Carib) virus 
vaccine. I. Pre-clinical studies. American Journal of Tropical Medicine and Hygiene, 43, 
pp. 212-218. 
Martinez-Barragan, J. J. & del Angel, R. M. (2001). Identification of putative coreceptor on 
Vero cells that participates in dengue 4 virus infection. Journal of Virology, 75, pp. 
7818-7827. 
Mathur, A.; Kulshreshtha, R. & Chaturvedi, U. C. (1987). Induction of secondary immune 
response by reactivated Japanese encephalitis virus in latently infected mice. 
Immunology, 60, pp. 481-484.  
McMinn, P. C.; Dalgarno, L. & Weir, R. C. (1996). A comparison of the spread of Murray 
Valley viruses of high or low neuroinvasiveness in the tissues of Swiss mice after 
peripheral inoculation. Virology, 220, pp. 414-423. 
Meyer, R.; Weissert, R.; Diem, R.; Storch, M. K.; Graaf, K. L.; Kramer, B. & Bähr, M. (2001). 
Acute neuronal apoptosis in a rat model of multiple sclerosis. The Journal of 
Neuroscience, 21, pp. 6214-6220. 
Misra. U. K. & Kalita, J. (1997). Movement disorders in Japanese encephalitis. Journal of 
Neurology, 244, pp. 299−303. 
Misra. U. K. & Kalita, J. (2010). Overview: Japanese encephalitis. Progress in Neurobiology, 91, 
pp. 108-120. 
Monath, T. P. (2002). Japanese encephalitis vaccines: current vaccines and future prospects. 
Current Topics in Microbiology and Immunology, 267, pp. 105-138. 
Monath, T. P., and F. X. Heinz. (1996). Flaviviruses, In: Fields Virology, 3rd ed., B. N. Fields, 
D. M. Knipe, P. M. Howley, R. M. Chanock, J. P. Melnick, T. P. Monath, B. 
www.intechopen.com
  
Flavivirus Encephalitis 
 
400 
Roizman, & S. E. Strauss, (Eds.), 961-1034, Lippincott-Raven Publishers, 
Philadelphia, USA. 
Morita, K. (2009). Molecular epidemiology of Japanese encephalitis in East Asia. Vaccine, 27, 
pp. 7131-7132. 
Muller, D. M.; Pender, M. P. & Greer, J. M. (2005). Blood-brain barrier disruption and lesion 
localization in experimental autoimmune encephalomyelitis with predominant 
cerebella and brainstem involvement. Journal of Neuroimmunology, 160, pp. 162-169. 
Myint, K. S. A.; Gibbons, R. V.; Perng, G. C. & Solomon, T. (2007). Unraveling the 
neuropathogenesis of Japanese encephalitis. Transactions of the Royal Society of 
Tropical Medicine and Hygiene, 101, pp. 955-956. 
Nabeshima, T.; Loan, H. T. K.; Sumiyoshi, M.; Haruda, Y.; Nga, P. H.; Huong, V. T.; Parquet, 
M. C.; Hasebe, F. & Morita, K. (2009). Evidence of frequent introduction of Japanese 
encephalitis virus from south-east Asia and continental east Asia to Japan. Journal of 
General Virology, 90, pp. 827-832. 
Nagy, P. D. & Bujarski, J. J. (1996). Homologous RNA recombination in brome mosaic virus: 
AU-rich sequences decrease the accuracy of crossovers. Journal of Virology, 70, pp. 
415-426. 
Nagy, P. D. & Jozef, J. B. (1997). Engineering of homologous recombination hotspots with 
AU-rich sequences in Brome mosaic virus. Journal of Virology, 71, pp. 3799-3810. 
Nargi-Aizenman, J. L. & Griffin, D. E. (2001). Sindbis virus-induced neuronal death is both 
necrotic and apoptotic and is ameliorated by N-methyl-D-aspartate receptor 
antagonists. Journal of Virology, 75, pp. 7114-7121. 
Nett, R. J.; Campbell, G. L. & Reisen, W. K. (2009). Potential for the emergence of Japanese 
encephalitis virus in California. Vector Borne and Zoonotic Diseases, 9, pp. 511-517. 
Nga, P. T.; del Carmen Parquet, M.; Cuong, V. D.; Ma, S. P.; Hasebe, F.; Inoue, S.; Mikino, Y.; 
Takagi, M.; Nam, V. S. & Morita, K. (2004). Shift in Japanese encephalitis virus 
(JEV) genotype circulating in northern Vietnam: implications for frequent 
introductions of JEV from Southeast Asia to East Asia. Journal of General Virology, 
85, pp. 1625-1631. 
Ni, H. & Barrett, A. D. T. (1998). Attenuation of Japanese encephalitis virus by selection of its 
mouse brain membrane receptor preparation escape variants. Virology, 241, pp. 30-
36. 
Ni, H. & Barrett, A. D. T. (1996).Molecular differences between wild-type Japanese 
encephalitis virus strains of high and low mouse neuroinvasiveness. Journal of 
General Virology, 77, pp. 1449-1455. 
Nidaira, M.; Taira, K.; Okano. S.; Shinzato, T.; Morikawa, T.; Tokumine. M.; Asato, Y.; Tada, 
Y.; Miyagi, K.; Matsuda, S.; Itokazu, K.; Kydaka, J.; Nakamura, M. & Tamanaha, K. 
(2009). Survey of Japanese encephalitis in pigs on Miyako, Ishigaki, Kume, and 
Yonaguri islands in Okinawa, Japan. Japanese Journal of Infectious Diseases, 62, pp. 
220-224. 
Nitatpattana, N.; Dubot-Pérès, A.; Gouilh, M. A.; Souris, M.; Barbazan, P.; Yoksan, S.; de 
Lamballerie, X. & Gonzalez, J. P. (2008). Change in Japanese encephalitis virus 
distribution, Thailand. Emerging Infectious Diseases, 14, pp. 1762-1765. 
Nitayaphan, S.; Grant, J. A. & Chang, G. J. (1990). Nucleotide sequence of the virulent SA-14 
strain of Japanese encephalitis virus and its attenuated vaccine derivative, SA14-14-
2. Virology, 177, pp. 541-552. 
www.intechopen.com
 
Genetic Evolution of Japanese Encephalitis Virus 
 
401 
Pyke, A. T.; Williams, D. T.; Nisbet, D. J.; van den Hurk, A. F.; Taylor, C. T.; Johansen, C. A.; 
Macdonald, J.; Hall, R. A.; Simmons, R. J.; Mason, R. J.; Lee, J. M.; Ritchie, S. A.; 
Smith, G. A. & Mackenzie, J. S. (2001). The appearance of a second genotype of 
Japanese encephalitis virus in the Australasian region. American Journal of Tropical 
Medicine and Hygiene, 65, pp. 747-753. 
Ramos-Castaneda, J.; Imbert, J. L.; Barron, B. L. & Ramos, C. (1997). A 65-kDa trypsin-
sensible membrane cell protein as a possible receptor for dengue virus in cultured 
neuroblastoma cells. Journal of Neurovirology, 3, pp. 435-440. 
Ravi, V.; Taly, A. B.; Shankar, S. K.; Shenoy, P. K.; Desai, A.; Nagaraja, D.; Gourie-Devi, M. & 
Chandramuki, A. (1994). Association of Japanese encephalitis virus infection with 
Guillain–Barré syndrome in endemic area of South India. Acta Neurologica 
Scandinavica, 90, pp. 67-72. 
Ren, J.; Ding, T.; Zhang, W.; Song, J. & Ma, W. (2007). Does Japanese encephalitis virus share 
the same cellular receptor with other mosquito-borne flaviviruses on the C6/36 
mosquito cells? Virology Journal, 4, pp. 83. 
Rey, F. A.; Heinz, F. X.; Mandl, C.; Kunz, C. & Harrison, S. C. (1995). The envelope 
glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature, 375, pp. 
291-298. 
Ritchie, S. A. & Rochester, W. (2001).Wind-blown mosquitoes and introduction of Japanese 
encephalitis into Australia. Emerging Infectious Diseases, 7, pp. 900-903. 
Rohayem, J.; Münch, J. & Rethwilm, A. (2005). Evidence of recombination in the norovirus 
capsid gene. Journal of Virology, 79, pp. 4977-4990. 
Rosen, L. (1986). The natural history of Japanese encephalitis virus. Annual Review of 
Microbiology, 40, pp. 395-414. 
Rothwell, S. W.; Putnak, R. & LaRussa, V. E. (1996). Dengue-2 virus infection of human bone 
marrow characterization of Dengue-2 antigen-positive stromal cells. American 
Journal of Tropical Medicine and Hygiene, 54, pp. 503-510. 
Samuel, M. A.; Morrey, J. D. & Diamond, M. S. (2007). Caspase 3-dependent cell death of 
neurons contributes to the pathogenesis of West Nile virus encephalitis. Journal of 
Virology, 81, pp. 2614-2623. 
Sarma, J. D. (2010). A mechanism of virus-induced demyelination. Interdisciplinary 
perspectives on infectious diseases, Article ID 109239. 
Schneider, W. L. & Roossinck, M. J. (2001). Genetic diversity in RNA virus quasispecies is 
controlled by host-virus interactions. Journal of Virology 75, pp. 6566-6571. 
Schuh, A. J.; Tesh, R. B. & Barrett, A. D. T. (2011). Genetic characterization of Japanese 
encephalitis virus genotype II strains isolated from 1951 to 1978. Journal of General 
Virology, 92, pp. 516-527. 
Sejvar, J. J.; Bode, A. V.; Marfin, A. A.; Campbell, G. L.; Ewing, D.; Mazowiecki, M.; Pavot, P. 
V.; Schmitt, J.; Pape, J.; Biggerstaff, B. J. & Petersen, L. R. (2005). West Nile virus-
associated flaccid paralysis. Emerging Infectious Diseases, 11, pp. 1021-1027. 
Shapka, N. & Nagy, P. D. (2004). The AU-Rich RNA recombination hot spot sequence of 
Brome mosaic virus is functional in tombusviruses: implications for the mechanism 
of RNA recombination. Journal of Virology, 78, pp. 2288-2300. 
Shope, R. E. & Sather, G. E. (1979). Arboviruses, In: Diagnostic procedures for viral, rickettsial, 
and chlamydial infections, 5th ed., E. H. Lennette & N. J. Schmidt , (Ed.), 767-814. 
American Public Health Association, Inc., Washington, D.C., USA. 
www.intechopen.com
  
Flavivirus Encephalitis 
 
402 
Solomon, T. & Vaughn, D. W. (2002). Pathogenesis and clinical features of Japanese 
encephalitis and West Nile virus infections. Current Topics in Microbiology and 
Immunology, 267, pp. 171−194. 
Solomon, T. (2004). Flavivirus encephalitis. New England Journal of Medicine, 351, pp. 370-378. 
Solomon, T.; Dung, N. M.; Kneen, R.; Gainsborough, M.; Vaughn, D. W.; Khanh, V. T. (2000). 
Japanese encephalitis. Journal of Neurology, Neurosurgery & Psychiatry, 68, pp. 405-
415. 
Solomon, T.; Ni, H.; Beasley, D. W. C.; Ekkelenkamp, M.; Cardosa, M. J. & Barrett A. D. T. 
(2003). Origin and evolution of Japanese encephalitis virus in Southeast Asia. 
Journal of Virology, 77, pp. 3091-3098. 
Stamatovic, S. M.; Shakui, P.; Keep, R. F.; Moore, B. B.; Kunkel, S. L.; Van Rooijen, N. & 
Andjelkovic, A. V. (2005). Monocyte chemoattractant protein-1 regulation of blood-
brain barrier permeability. Journal of Cerebral Blood Flow & Metabolism, 25, pp. 593–
606. 
Stephens, E. B.; Singh, D. K.; Kohler, M. E.; Jackson, M.; Pacyniak, E. & Berman, N. E. J. 
(2003). The primary phase of infection by pathogenic simian-human 
immunodeficiency virus results in disruption of the blood-brain barriers. AIDS 
Research and Human Retroviruses, 19, pp. 837−846. 
Stiasny, K. & Heinz, F. X. (2006). Flavivirus membrane fusion. Journal of General Virology, 87, 
pp. 2755–2766. 
Stohlman, S. A. & Hinton, D. R. (2001). Viral induced demyelination. Brain Pathology, 11, pp. 
92-106. 
Su, C. M.; Liao, C. L.; Lee, Y. L.; Lin, Y.-L. (2001). Highly sulfated forms of heparin sulfate 
are involved in Japanese encephalitis virus infection. Virology, 286, pp. 206-215. 
Sumiyoshi, H.; Mori, C.; Fuke, I.; Morita, K.; Kuhara, S.; Kondou, J.; Kikuchi, Y.; Nagamatu, 
H. & Igarashi, A. (1987). Complete nucleotide of the Japanese encephalitis virus 
genome RNA. Virology, 161, pp. 479-510. 
Suri, N. K. & Banerjee, K. (1995). Growth and cytopathic effect of Japanese encephalitis in 
astrocyte-enriched cell cultures from neonatal mouse brains. Acta Virologica, 39, pp. 
143-148.  
Sztuba-Solinska, J.; Urbanowicz, A.; Figlerowicz, M. & Bujarski, J. J. (2011). RNA-RNA 
recombination in plant virus replication and evolution. Annual Review of 
Phytopathology, 49, (in press) 
Tajima, S.; Nerome, R.; Nukui, Y.; Kato, F.; Takasaki, T. & Kurane, I. (2010). A single 
mutation in the Japanese encephalitis virus E protein (S123R) increases its growth 
rate in mouse neuroblastoma cells and its pathogenicity in mice. Virology, 396, pp. 
298-304. 
Thompson, J. D.; Hinggins, D. G. & Gibson, T. J. (1994). CLUSTAL W: improving the 
sensitivity of progressive multiple sequence alignment through sequence 
weighting, position specific gap penalties and weight matrix choice. Nucleic Acid 
Research, 22, pp. 4673-4680. 
Tolou, H. J. G.; Couissinier-Paris, P.; Durand, J. P.; Mercier, V.; de Pina, J. J.; de Micco, P.; 
Billoir, F.; Charrel, R. N. & de Lamballerie, X. (2001). Evidence for recombination in 
natural populations of dengue virus type 1 based on the analysis of complete 
genome sequences. Journal of General Virology, 82, pp. 1283-1290. 
www.intechopen.com
 
Genetic Evolution of Japanese Encephalitis Virus 
 
403 
Trent, D. W.; Grant, J. A.; Rosen, L. & Monath, T. P. (1983). Genetic variation among dengue 
2 viruses of different geographic origin. Virology, 128, pp. 271-284. 
Trent, D. W.; Kinney, R. M.; Johnson, B. J.; Vorndam, A.V.; Grant, J. A.; Deubel, V.; Rice, 
C.M. & Hahn, C. (1987). Partial nucleotide sequence of St. Louis encephalitis virus 
RNA: structural proteins, NS1, NS2a, and NS2b. Virology, 156, pp. 293-304. 
Tseng, Y. F.; Wang, C. C.; Liao, S. K.; Chuang, C. K. & Chen, W. J. (2011). Autoimmunity-
related demyelination in infection by Japanese encephalitis virus. Journal: Journal of 
Biomedical Science, 18, pp. 20. 
Tsunoda, I.; Kuang, L. Q.; Libbey, J. E. & Fujinami, R. S. (2003). Axonal injury heralds virus-
induced demyelination. The American Journal of Pathology, 162, pp. 1259-1269. 
Tung, W. H.; Tsai, H. W.; Lee, I. T.; Hsieh, H. L.; Chen, W. J.; Chen, Y. L. & Yang, C. M. 
(2010). Japanese encephalitis virus induces matrix metalloproteinase-9 expression 
via the ROS/MAPKs-dependent NF-κB signaling pathway in rat brain astrocytes. 
British Journal of Pharmacology, 161, pp. 1566-1583. 
Turner, P. E. & Chao, L. (1998). Sex and evolution of intrahost competition in RNA virus φ6. 
Genetics, 150, pp. 523-532. 
Twiddy, S. S. & Holmes, E. C. (2003). The extent of homologous recombination in members 
of the genus Flavivirus. Journal of General Virology, 84, pp. 429-440. 
Uchil, P. D. & Satchidanandam, V. (2001). Phylogenetic analysis of Japanese encephalitis 
virus: envelope gene based analysis reveals a fifth genotype, geographic clustering, 
and multiple introductions of the virus into the Indian subcontinent. American 
Journal of Tropical Medicine and Hygiene, 65, pp. 242-251. 
Umenai, T.; Krzysko, R.; Bektimirov, T. A. & Assaad, F. A. (1985). Japanese encephalitis: 
current worldwide status. Bulletin of World Health Organization, 63, 625-631. 
Unni, S. K.; Růžek, D.; Chhatbar, C.; Mishra, R.; Johri, M. K.; Singh, S. K. (2011). Japanese 
encephalitis virus: From genome to infectome. Microbes and Infection, 13, pp. 312-
321. 
van den Hurk, A. F.; Ritchie, S. A. & Mackenzie, J. S. (2009). Ecology and geographical 
expansion of Japanese encephalitis virus. Annual Review of Entomology, 54, pp. 17-
35. 
van den Hurk, A. F.; Ritchie, S. A.; Johansen, C. A.; Mackenzie, J. S. & Smith, G. A. (2008). 
Domestic pigs and Japanese encephalitis virus infection, Australia. Emerging 
Infectious Diseases, 14, pp. 1173-1178. 
Vasilakis, N; Deardorff, E. R.; Kenney, J. L.; Rossi, S. L. & Hanley, K.A. (2009) Mosquitoes 
put the brake on arbovirus evolution: experimental evolution reveals slower 
mutation accumulation in mosquito than vertebrate cells. PLoS Pathogens, 5, pp. 
e1000467. 
Wang, H.; Takasaki, T.; Fu, S, Sun, X.; Zhang, H.; Wang, Z.; Hao, Z.; Zhang, J.; Tang, Q.; 
Kotaki, A.; Tajima, S.; Liang, X.; Yang, W.; Kurane, I. & Liang, G. (2007). Molecular 
epidemiological analysis of Japanese encephalitis virus in China. Journal of General 
Virology, 88, pp. 885-894. 
Wang, L.; Fu, S.; Zhang, H.; Ye, X.; Yu, D.; Deng, Z.; Yuan, J.; Zhai, Y.; Li, M.; Lv, Z.; Chen, 
W.; Jiang, H.; Gao, X.; Cao, Y.; Wang, H.; Tang, Q. & Liang, G. (2010). Identification 
and isolation of Genotype-I Japanese encephalitis virus from encephalitis patients. 
Virology Journal, 7, pp. 345. 
www.intechopen.com
  
Flavivirus Encephalitis 
 
404 
Wang, T.; Town, T.; Alexopoulou, L.; Anderson, J. F.; Fikrig, E. & Flavell, R. A. (2004). Toll-
like receptor 3 mediates West Nile virus entry into the brain causing lethal 
encephalitis. Nature Medicine, 10, pp. 1366−1373. 
Weaver, S. C.; Rico-Hesse, R. & Scott, T. W. (1992). Genetic diversity and slow rates of 
evolution in New World alphaviruses. Current Topics in Micriobiology and 
Immunology, 176, pp. 99-117. 
Weng, M. H.; Lien, J. C.; Wang, Y. M,.; Lin, C. C.; Lin, H. C. & Chin, C. (1999). Isolation of 
Japanese encephalitis virus from mosquitoes collected in Northern Taiwan between 
1995 and 1996. Journal of Microbiology, Immunology, and Infection, 32, pp. 9-13. 
Westaway, E. G.; Brinton, M. A.; Gaidamovich, S, Y.; Horzinek, M. C.; Igarashi, A.; 
Kääriäinen, L.; Lvov, D. K.; Porterfield, J. S.; Russell, P. K. & Trent, D. W. (1985). 
Flaviviridae. Intervirology, 24, pp. 183-192. 
White, K. A. & Morris, T. J. (1995). RNA determinants of junction site selection in RNA virus 
recombinants and defective interfering RNAs. RNA, 1, pp. 1029-1040. 
Whitley, R. J. & Gnann, J. W. (2002). Viral encephalitis: familiar infections and emerging 
pathogens. Lancet, 359, pp. 507−513. 
Wierzchoslawski, R. & Bujarski, J. (2006). Efficient in vitro system of homologous 
recombination in Brome mosaic bromovirus. Journal of Virology, 80, pp. 6182-6187. 
Worobey, M. & Holmes, E. C. (1999). Evolutionary aspects of recombination in RNA viruses. 
Journal of General Virology, 80, pp. 2535-2543. 
Wu, S. C.; Lian, W. C.; Hsu, L. C.; Wu, Y. C. & Liau. M. Y. (1998). Antigenic characterization 
of nine wild-type Taiwanese isolates of Japanese encephalitis virus as compared 
with two vaccine strains. Virus Research, 55, pp. 83-91. 
Wu, Y. C.; Huang, Y. S.; Chien, L. J.; Lin, T. L.; Yueh, Y. Y.; Tseng, W. L.; Chang,K. J.  & 
Wang, G. R. (1999). The epidemiology of Japanese encephalitis on Taiwan during 
1966-1997. American Journal of Tropical Medicine and Hygiene, 61, pp. 78-84. 
Xia, S. Y.; Guzman, Ha.; Zhang, H.; Travassos, da Rosa. A. P. A. & Tesh, R. B. (2001). West 
Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West 
Nile encephalitis. Emerging Infectious Diseases, 7, pp. 714−722. 
Yamada, M.; Nakamura, K.; Yoshii, M. & Kaku, Y. (2004). Nonsuppurative encephalitis in 
piglets after experimental inoculation of Japanese encephalitis flavivirus isolated 
from pigs. Veterinary Pathology, 41, pp. 62−67. 
Yoshida, Y.; Tabei, Y.; Hasegawa, M.; Nagashima, M. & Morozumi, S. (2005). Genotypic 
analysis of Japanese encephalitis virus strains isolated from swine in Tokyo, Japan. 
Japanese Journal of Infectious Diseases, 58, pp. 259-261. 
Yun, S. M.; Cho, J. E.; Ju, Y. R.; Kim. S. Y.; Ryou, J.; Han, M. G.; Choi, W. Y. & Jeong, Y. E. 
(2010). Molecular epidemiology of Japanese encephalitis virus circulating in South 
Korea, 1983-2005. Virology Journal, 7, pp. 127. 
Zhao, Z.; Date, T.; Li, Y.; Kato, T.; Miyamoto, M.; Yasui, K. & Wakita, T. (2005). 
Characterization of the E-138 (Glu/Lys) mutation in Japanese encephalitis virus by 
using a stable, full-length, infectious cDNA clone. Journal of General Virology, 86, pp. 
2209-2220. 
Zhou, Y.; Ray, D.; Zhao, Y.; Dong, H.; Ren, S.; Li, Z.; Guo, Y.; Bernard, K. A.; Shi, P. Y. & Li, 
H. (2007). Structure and function of flavivirus NS5 methyltransferase. Journal of 
Virology, 81, pp. 3891-3903.  
www.intechopen.com
Flavivirus Encephalitis
Edited by Dr. Daniel Ruzek
ISBN 978-953-307-669-0
Hard cover, 478 pages
Publisher InTech
Published online 30, September, 2011
Published in print edition September, 2011
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Encephalitis is an inflammation of the brain tissue associated with clinical evidence of brain dysfunction. The
disease is of high public health importance worldwide due to its high morbidity and mortality. Flaviviruses, such
as tick-borne encephalitis virus, Japanese encephalitis virus, Murray Valley encephalitis virus, or St. Louis
encephalitis virus, represent important causative agents of encephalitis in humans in various parts of the
world. The book Flavivirus Encephalitis provides the most recent information about selected aspects
associated with encephalitic flaviviruses. The book contains chapters that cover a wide spectrum of subjects
including flavivirus biology, virus-host interactions, role of vectors in disease epidemiology, neurological
dengue, and West Nile encephalitis. Special attention is paid to tick-borne encephalitis and Japanese
encephalitis viruses. The book uniquely combines up-to-date reviews with cutting-edge original research data,
and provides a condensed source of information for clinicians, virologists, pathologists, immunologists, as well
as for students of medicine or life sciences.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Ching-Kai Chuang and Wei-June Chen (2011). Genetic Evolution of Japanese Encephalitis Virus, Flavivirus
Encephalitis, Dr. Daniel Ruzek (Ed.), ISBN: 978-953-307-669-0, InTech, Available from:
http://www.intechopen.com/books/flavivirus-encephalitis/genetic-evolution-of-japanese-encephalitis-virus
© 2011 The Author(s). Licensee IntechOpen. This chapter is distributed
under the terms of the Creative Commons Attribution-NonCommercial-
ShareAlike-3.0 License, which permits use, distribution and reproduction for
non-commercial purposes, provided the original is properly cited and
derivative works building on this content are distributed under the same
license.
